Search results for ERG

441 hits were found for ERG

# Family MCID Name MIFTS Score
1
P PRS040 Prostate Cancer 97 6.422
2
EWN003 Ewing Sarcoma 69 5.932
3
P MYL006 Myeloid Leukemia 61 5.571
4
SRC014 Sarcoma 67 4.809
5
MYX005 Myxoid Liposarcoma 64 3.372
6
c RTN035 Retinal Cone Dystrophy 3b 30 3.155
7
PRS006 Prostatic Acinar Adenocarcinoma 33 2.413
8
EXT052 Extraskeletal Ewing Sarcoma 35 2.373
9
RTN023 Retinitis 46 0.272
10
NRR001 Neuroretinitis 46 0.272
11
P RTN008 Retinitis Pigmentosa 77 0.268
12
c LKM061 Leukemia, Acute Myeloid 84 0.254
13
P RTN016 Retinal Degeneration 56 0.227
14
YMN001 Yemenite Deaf-Blind Hypopigmentation Syndrome 66 0.216
15
P MCR115 Microvascular Complications of Diabetes 5 67 0.204
16
INT323 Intraocular Pressure Quantitative Trait Locus 64 0.204
17
P LYM031 Lymphocytic Leukemia 56 0.198
18
P RTN018 Retinal Disease 53 0.198
19
P NGH001 Night Blindness 48 0.189
20
RTN017 Retinal Detachment 62 0.176
21
P LKM002 Leukemia 69 0.169
22
P LKM062 Leukemia, Acute Lymphoblastic 68 0.162
23
P ADN016 Adenocarcinoma 65 0.158
24
P CNG010 Congenital Stationary Night Blindness 54 0.158
26
P CND005 Cone Dystrophy 41 0.151
27
P CTR002 Cataract 62 0.142
28
c ACT073 Acute Leukemia 59 0.138
29
DWN001 Down Syndrome 70 0.134
30
RTN209 Retinoschisis 1, X-Linked, Juvenile 57 0.134
31
PRC049 Precursor T-Cell Acute Lymphoblastic Leukemia 49 0.129
32
PTH003 Pathologic Nystagmus 53 0.125
33
P MYP006 Myopia 58 0.120
34
AMB002 Amblyopia 51 0.120
35
SPP007 Suppression Amblyopia 37 0.120
36
P LNG028 Long Qt Syndrome 68 0.115
37
P OPT006 Optic Nerve Disease 59 0.115
38
P OPN001 Open-Angle Glaucoma 50 0.115
39
P ACH003 Achromatopsia 61 0.109
40
SPN035 Spindle Cell Sarcoma 57 0.109
41
P RTN022 Retinal Vein Occlusion 50 0.109
42
c CNT016 Central Retinal Vein Occlusion 48 0.109
43
P 3MT016 3-Methylglutaconic Aciduria, Type Iii 64 0.104
44
P OPT009 Optic Neuritis 55 0.104
45
NRT004 Neuritis 52 0.104
46
OCC002 Occult Macular Dystrophy 42 0.104
47
SCT002 Scotoma 38 0.104
48
CHR178 Chromosomal Triplication 36 0.104
49
CYT019 Cytogenetically Normal Acute Myeloid Leukemia 33 0.104
50
P MSC005 Muscular Dystrophy 68 0.098
51
MGK001 Megakaryocytic Leukemia 65 0.098
52
OCL006 Ocular Hypertension 52 0.098
53
FND002 Fundus Dystrophy 52 0.098
54
c INH030 Inherited Retinal Disorder 48 0.098
55
P CNR004 Cone-Rod Dystrophy 2 72 0.091
56
MSC157 Muscular Dystrophy, Duchenne Type 70 0.091
57
SPP011 Suppression of Tumorigenicity 12 61 0.091
58
PRS045 Prostatic Hypertrophy 55 0.091
59
RTN003 Retinal Ischemia 52 0.091
60
P OGC005 Oguchi Disease 39 0.091
61
c NGH029 Night Blindness, Congenital Stationary, Type 1e 35 0.091
62
FND001 Fundus Albipunctatus 60 0.085
63
ANG020 Angiosarcoma 59 0.085
64
P UVT001 Uveitis 58 0.085
65
P NRP001 Neuropathy 57 0.085
66
HYP276 Hypercarotenemia and Vitamin a Deficiency, Autosomal Dominant 55 0.085
67
PRS021 Prostatic Adenoma 52 0.085
68
KRT002 Keratomalacia 47 0.085
69
P RTN014 Retinal Artery Occlusion 46 0.085
70
MCL003 Macular Holes 44 0.085
71
BRN026 Branch Retinal Artery Occlusion 41 0.085
72
PPL052 Papillomatosis, Confluent and Reticulated 34 0.085
73
c EXD008 Exudative Vitreoretinopathy 1 69 0.077
74
P LPS002 Liposarcoma 62 0.077
75
MCL006 Macular Retinal Edema 52 0.077
76
ALB002 Albinism 48 0.077
77
RFR003 Refractive Error 44 0.077
78
c CNT028 Central Retinal Artery Occlusion 40 0.077
79
P CNG024 Congenital Nystagmus 36 0.077
80
MLN046 Melanoma-Associated Retinopathy 25 0.077
81
P RTN024 Retinoblastoma 74 0.069
82
P NRB010 Neuroblastoma 1 66 0.069
83
HYD058 Hydrops, Lactic Acidosis, and Sideroblastic Anemia 63 0.069
84
c LNG047 Long Qt Syndrome 2 57 0.069
85
ENH001 Enhanced S-Cone Syndrome 56 0.069
86
CHL152 Childhood Acute Lymphocytic Leukemia 50 0.069
87
PRS129 Prostatic Hyperplasia, Benign 49 0.069
88
RTN020 Retinal Vascular Disease 49 0.069
89
47X002 47,xyy 49 0.069
90
P EPT012 Epithelioid Sarcoma 49 0.069
91
P OPT070 Optic Nerve Hypoplasia, Bilateral 47 0.069
92
c FML008 Familial Retinoblastoma 46 0.069
93
P SDR002 Siderosis 42 0.069
94
GLD003 Goldmann-Favre Syndrome 28 0.069
95
P MLT020 Multiple Sclerosis 73 0.060
96
SMT004 Smith-Lemli-Opitz Syndrome 67 0.060
97
MYL031 Myeloproliferative Neoplasm 66 0.060
98
P VSC007 Vascular Disease 65 0.060
99
KRN002 Kearns-Sayre Syndrome 64 0.060
100
P ANR048 Aniridia 1 64 0.060
101
ISC004 Ischemia 62 0.060
102
EYD002 Eye Disease 59 0.060
103
P STR022 Stargardt Disease 59 0.060
104
HYP266 Hypoxia 58 0.060
105
P USH001 Usher Syndrome 58 0.060
106
ERY051 Erythroleukemia, Familial 58 0.060
107
HPT046 Hepatic Veno-Occlusive Disease 56 0.060
108
HMT018 Hematopoietic Stem Cell Transplantation 54 0.060
109
c ACT020 Acute T Cell Leukemia 54 0.060
110
c CNR007 Cone-Rod Dystrophy 6 51 0.060
111
P END047 Endophthalmitis 50 0.060
112
RTN187 Retinitis Pigmentosa-Deafness Syndrome 48 0.060
113
DBT006 Diabetic Macular Edema 46 0.060
114
c CHR095 Chronic Progressive External Ophthalmoplegia 46 0.060
115
c NGH026 Night Blindness, Congenital Stationary, Type 1a 46 0.060
116
BST008 Bestrophinopathy, Autosomal Recessive 46 0.060
117
c PLM170 Pulmonary Venoocclusive Disease 1, Autosomal Dominant 45 0.060
118
MSN004 Mesenchymal Cell Neoplasm 45 0.060
119
P HYP058 Hypervitaminosis a 45 0.060
120
KHN001 Kuhnt-Junius Degeneration 45 0.060
121
ANX004 Anoxia 44 0.060
122
P PLM025 Pulmonary Venoocclusive Disease 42 0.060
123
c RTN150 Retinitis Pigmentosa 10 40 0.060
124
FST001 Foster-Kennedy Syndrome 40 0.060
125
RPD005 Rapidly Involuting Congenital Hemangioma 38 0.060
126
CNC014 Cancer-Associated Retinopathy 35 0.060
127
c MCR122 Microphthalmia, Isolated 5 34 0.060
128
MCL057 Macular Dystrophy with Central Cone Involvement 32 0.060
129
c CND012 Cone Dystrophy 4 28 0.060
130
P CNR040 Cone-Rod Dystrophy and Hearing Loss 1 24 0.060
131
P MCL035 Macular Dystrophy, Retinal, 2 23 0.060
132
P LNG032 Lung Cancer 99 0.049
133
CYS001 Cystic Fibrosis 84 0.049
134
OST012 Osteoarthritis 80 0.049
135
P BLD134 Bladder Cancer 79 0.049
136
c PLM164 Pulmonary Hypertension, Primary, 1 79 0.049
137
MYL009 Myelodysplastic Syndrome 72 0.049
138
P GRF003 Graft-Versus-Host Disease 71 0.049
139
P CRD119 Cardiac Arrest 71 0.049
140
MLN008 Melanoma 68 0.049
141
P LBR001 Leber Congenital Amaurosis 67 0.049
142
OST159 Osteogenic Sarcoma 67 0.049
143
P RHB008 Rhabdoid Tumor Predisposition Syndrome 1 65 0.049
144
P ENC018 Encephalopathy 64 0.049
145
P GLM045 Glioma 64 0.049
146
ACT119 Acute Promyelocytic Leukemia 63 0.049
147
c GLC092 Glaucoma, Primary Open Angle 63 0.049
148
P RHB003 Rhabdomyosarcoma 62 0.049
149
P HMN010 Hemangioma 62 0.049
150
RHB001 Rhabdoid Cancer 62 0.049
151
ALS001 Alstrom Syndrome 60 0.049
152
MSC152 Muscular Dystrophy, Becker Type 60 0.049
153
SRC027 Sarcoma, Synovial 60 0.049
154
c CRD186 Ceroid Lipofuscinosis, Neuronal, 3 58 0.049
155
AGN016 Aging 58 0.049
156
c LKM060 Leukemia, Acute Lymphoblastic 3 57 0.049
157
P CHN012 Chondrosarcoma 57 0.049
158
P SML001 Small Cell Carcinoma 55 0.049
159
NNR004 Nonarteritic Anterior Ischemic Optic Neuropathy 53 0.049
160
IMP005 Impotence 53 0.049
161
OCL069 Ocular Motor Apraxia 53 0.049
162
c ACT135 Acute Graft Versus Host Disease 52 0.049
163
GYR004 Gyrate Atrophy of Choroid and Retina 52 0.049
164
RTN193 Retinitis Pigmentosa and Erythrocytic Microcytosis 52 0.049
165
TRT020 Tritanopia 51 0.049
166
CHL061 Childhood Leukemia 49 0.049
167
EWN002 Ewing's Family of Tumors 48 0.049
168
ATN005 Autonomic Dysfunction 48 0.049
169
PTT037 Pituitary Tumors 47 0.049
170
P CLR019 Color Blindness 47 0.049
171
c LBR004 Leber Congenital Amaurosis 1 47 0.049
172
BRD025 Birdshot Chorioretinopathy 46 0.049
173
MYP002 Myoepithelial Carcinoma 45 0.049
174
c PCH010 Pachyonychia Congenita 3 43 0.049
175
c PRG130 Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 1 43 0.049
176
CLR033 Color Vision Deficiency 43 0.049
177
P VTL001 Vitelliform Macular Dystrophy 43 0.049
178
SPN050 Spinocerebellar Degeneration 43 0.049
179
c PRG039 Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 3 43 0.049
180
PRL047 Prolonged Electroretinal Response Suppression 41 0.049
181
c PRG040 Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 4 40 0.049
182
c PRG038 Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 2 40 0.049
183
c RTN172 Retinitis Pigmentosa 1 39 0.049
184
c LBR012 Leber Congenital Amaurosis 2 39 0.049
185
c RTN054 Retinitis Pigmentosa 25 38 0.049
186
c RTN048 Retinitis Pigmentosa 19 38 0.049
187
c CND011 Cone Dystrophy 3 36 0.049
188
HRD016 Hereditary Retinal Dystrophy 36 0.049
189
P HRD217 Hereditary Optic Neuropathy 35 0.049
190
AST003 Asthenopia 34 0.049
191
BST007 Best Vitelliform Macular Dystrophy 34 0.049
192
BRN041 Bornholm Eye Disease 34 0.049
193
c RTN036 Retinal Cone Dystrophy 4 33 0.049
194
c NGH007 Night Blindness, Congenital Stationary, Type 1b 33 0.049
195
CNR033 Cone-Rod Synaptic Disorder, Congenital Nonprogressive 32 0.049
196
c CNR038 Cone-Rod Dystrophy, X-Linked, 3 32 0.049
197
c NGH010 Night Blindness, Congenital Stationary, Autosomal Dominant 2 30 0.049
198
ATM076 Autoimmune Retinopathy 29 0.049
199
c ACH038 Achromatopsia 7 27 0.049
200
c OGC001 Oguchi Disease 1 26 0.049
201
c RTN157 Retinitis Pigmentosa 37 26 0.049
202
c RTN213 Retinitis Pigmentosa 80 26 0.049
203
c CNR012 Cone-Rod Dystrophy 11 24 0.049
204
c RTN192 Retinitis Pigmentosa 77 23 0.049
205
c NGH008 Night Blindness, Congenital Stationary, Autosomal Dominant 3 22 0.049
206
c NGH022 Night Blindness, Congenital Stationary, Type 1g 21 0.049
207
c RTN196 Retinitis Pigmentosa 78 20 0.049
208
c RTN217 Retinitis Pigmentosa 83 19 0.049
209
RTN191 Retinal Dystrophy with or Without Extraocular Anomalies 19 0.049
210
c RTN219 Retinitis Pigmentosa 85 18 0.049
211
c CNR041 Cone-Rod Dystrophy and Hearing Loss 2 18 0.049
212
ACT186 Acute Megakaryoblastic Leukemia in Down Syndrome 17 0.049
213
MCL029 Macular Degeneration, X-Linked Atrophic 13 0.049
214
P OVR042 Ovarian Cancer 89 0.035
215
P GST053 Gastric Cancer 85 0.035
216
MYL069 Myeloma, Multiple 85 0.035
217
MLR004 Malaria 82 0.035
218
P PRK057 Parkinson Disease, Late-Onset 77 0.035
219
GST019 Gastrointestinal Stromal Tumor 76 0.035
220
P SCH015 Schizophrenia 76 0.035
221
KPS004 Kaposi Sarcoma 75 0.035
222
GLB002 Glioblastoma 74 0.035
223
SVR004 Severe Combined Immunodeficiency 74 0.035
224
P FML011 Familial Adenomatous Polyposis 73 0.035
225
MLT157 Multiple System Atrophy 1 71 0.035
226
P NJM001 Nijmegen Breakage Syndrome 70 0.035
227
P HYP086 Hypothyroidism 70 0.035
228
BHC003 Behcet Syndrome 70 0.035
229
P LYM118 Lymphoma 70 0.035
230
P OST001 Osteopetrosis 70 0.035
231
c WLM013 Wilms Tumor 1 69 0.035
232
P PLM037 Pulmonary Hypertension 69 0.035
233
KRT019 Keratitis, Hereditary 69 0.035
234
P ATS364 Autism 68 0.035
235
P TMP003 Temporal Arteritis 68 0.035
236
P DMN002 Dementia 68 0.035
237
SKN019 Skin Melanoma 68 0.035
238
SCH036 Scheie Syndrome 68 0.035
239
c CRB175 Cerebral Arteriopathy, Autosomal Dominant, with Subcortical Infarcts and Leukoencephalopathy, Type 1 67 0.035
240
P ASP006 Aspergillosis 67 0.035
241
c VNT034 Ventricular Fibrillation, Paroxysmal Familial, 1 67 0.035
242
c MCR129 Microvascular Complications of Diabetes 1 67 0.035
243
P THR014 Thrombocytopenia 67 0.035
244
ALP042 Alpha/beta T-Cell Lymphopenia with Gamma/delta T-Cell Expansion, Severe Cytomegalovirus Infection, and Autoimmunity 67 0.035
245
c SML038 Small Cell Cancer of the Lung 67 0.035
246
P DBT009 Diabetes Mellitus 66 0.035
247
P BRD002 Bardet-Biedl Syndrome 66 0.035
248
MSC007 Muscle Hypertrophy 65 0.035
249
ALL026 Allergic Hypersensitivity Disease 65 0.035
250
P CHR071 Charcot-Marie-Tooth Disease 65 0.035
251
ATM096 Autoimmune Polyendocrine Syndrome, Type I, with or Without Reversible Metaphyseal Dysplasia 65 0.035
252
DPR016 Depression 64 0.035
253
P VSC011 Vasculitis 64 0.035
254
c RHB024 Rhabdomyosarcoma 2 64 0.035
255
P HRM001 Hermansky-Pudlak Syndrome 64 0.035
256
P ART005 Arteriovenous Malformation 63 0.035
257
c WLM018 Wilms Tumor 5 63 0.035
258
P MYP004 Myopathy 63 0.035
259
c CRD177 Ceroid Lipofuscinosis, Neuronal, 1 63 0.035
260
HYP066 Hyperglycemia 63 0.035
261
HYP020 Hyperprolactinemia 62 0.035
262
P THL005 Thalassemia 62 0.035
263
P SNS001 Sensorineural Hearing Loss 62 0.035
264
P MCP040 Mucopolysaccharidosis-Plus Syndrome 62 0.035
265
c NRD033 Neurodegeneration with Brain Iron Accumulation 2a 62 0.035
266
ATM095 Autoimmune Disease 62 0.035
267
CRD223 Cardiac Arrhythmia 61 0.035
268
WST001 West Syndrome 61 0.035
269
P BCL017 B-Cell Lymphoma 61 0.035
270
P CRD132 Cardiac Conduction Defect 61 0.035
271
P VTL004 Vitiligo-Associated Multiple Autoimmune Disease Susceptibility 1 61 0.035
272
GLB015 Glioblastoma Multiforme 60 0.035
273
IMM174 Immunodeficiency with Hyper-Igm, Type 1 60 0.035
274
PRT058 Pure Autonomic Failure 60 0.035
275
CHR072 Chordoma 60 0.035
276
ATY005 Atypical Teratoid Rhabdoid Tumor 60 0.035
277
c MCL013 Mucolipidosis Iv 60 0.035
278
P ATS308 Autosomal Dominant Cerebellar Ataxia 60 0.035
279
c CNG410 Congenital Heart Defects, Hamartomas of Tongue, and Polysyndactyly 59 0.035
280
P BPL003 Bipolar Disorder 59 0.035
281
c FBR046 Fibrosis of Extraocular Muscles, Congenital, 1 59 0.035
282
P OCL002 Oculocutaneous Albinism 58 0.035
283
CHL014 Cholera 58 0.035
284
P STR020 Strabismus 57 0.035
285
RLP002 Relapsing-Remitting Multiple Sclerosis 57 0.035
286
ACT200 Acute Monoblastic Leukemia 56 0.035
287
ATX031 Ataxia, Combined Cerebellar and Peripheral, with Hearing Loss and Diabetes Mellitus 56 0.035
288
ACT193 Acute Myeloid Leukemia with Abnormal Bone Marrow Eosinophils Inv(16)(p13q22) or T(16;16)(p13;q22) 56 0.035
289
DFF005 Diffuse Large B-Cell Lymphoma 56 0.035
290
c LBR014 Leber Congenital Amaurosis 4 55 0.035
291
P SNR003 Senior-Loken Syndrome 1 55 0.035
292
c SPN294 Spinocerebellar Ataxia 1 55 0.035
293
c FRS014 Fraser Syndrome 1 55 0.035
294
P HYP076 Hyperthyroidism 55 0.035
295
P ISL078 Isolated Ectopia Lentis 55 0.035
296
c LKM070 Leukemia, Acute Monocytic 55 0.035
297
HRL003 Hurler Syndrome 55 0.035
298
CHR081 Choroideremia 54 0.035
299
DBF001 D-Bifunctional Protein Deficiency 54 0.035
300
INT075 Intracranial Hypertension 54 0.035
301
PNC001 Pancytopenia 54 0.035
302
SPP010 Suppressor of Tumorigenicity 3 54 0.035
303
c FML191 Familial Long Qt Syndrome 54 0.035
304
CMB003 Combined T Cell and B Cell Immunodeficiency 53 0.035
305
AST006 Astigmatism 53 0.035
306
P MTC133 Mitochondrial Myopathy 53 0.035
307
c CRD183 Ceroid Lipofuscinosis, Neuronal, 2 52 0.035
308
c PST005 Posterior Uveitis 52 0.035
309
P MNC007 Monocytic Leukemia 52 0.035
310
P MYT002 Myotonic Dystrophy 52 0.035
311
OST011 Osteomalacia 51 0.035
312
ILS001 Ileus 51 0.035
313
P PRC012 Pericardial Effusion 51 0.035
314
ATX038 Ataxia and Polyneuropathy, Adult-Onset 51 0.035
315
APR001 Apraxia 50 0.035
316
ONC002 Onchocerciasis 50 0.035
317
DSM007 Desmoplastic Small Round Cell Tumor 50 0.035
318
MYL003 Myeloid Sarcoma 50 0.035
319
ALN001 Aland Island Eye Disease 50 0.035
320
c MSC042 Muscular Dystrophy-Dystroglycanopathy , Type B, 6 49 0.035
321
c LTN004 Late-Onset Retinal Degeneration 49 0.035
322
ATS010 Autosomal Recessive Disease 49 0.035
323
P OBS001 Obstructive Jaundice 49 0.035
324
CYT005 Cytomegalovirus Retinitis 49 0.035
325
PST048 Postural Orthostatic Tachycardia Syndrome 49 0.035
326
SPL018 Splenomegaly 48 0.035
327
PRX028 Peroxisomal Acyl-Coa Oxidase Deficiency 48 0.035
328
HYP781 Hypoascorbemia 48 0.035
329
P CHR637 Choroidal Dystrophy, Central Areolar, 1 48 0.035
330
c BPL002 Bipolar I Disorder 48 0.035
331
GLL048 Glial Tumor 48 0.035
332
ACT113 Acute Myeloblastic Leukemia with Maturation 48 0.035
333
SRS007 Sorsby Fundus Dystrophy 47 0.035
334
c OPT051 Opitz Gbbb Syndrome, Type I 46 0.035
335
NVS001 Neovascular Glaucoma 46 0.035
336
c STR084 Stargardt Disease 1 45 0.035
337
P EPT020 Epithelioid Hemangioendothelioma 45 0.035
338
INT054 Intraocular Lymphoma 45 0.035
339
FBR054 Fibroma 45 0.035
340
RTN001 Retinal Vasculitis 44 0.035
341
P MJR007 Major Affective Disorder 1 44 0.035
342
EST005 Esotropia 44 0.035
343
HMP001 Hemopericardium 44 0.035
344
ONC003 Oncogenic Osteomalacia 44 0.035
345
CHN010 Chondroma 44 0.035
346
SPN032 Spindle Cell Carcinoma 44 0.035
347
LNG020 Lung Oat Cell Carcinoma 43 0.035
348
c MCL066 Macular Dystrophy, Vitelliform, 2 43 0.035
349
CHR078 Chorioretinitis 43 0.035
350
c USH035 Usher Syndrome Type 2 43 0.035
351
P HYP265 Hypotonia 43 0.035
352
CD4003 Cd40 Ligand Deficiency 43 0.035
353
LYM116 Lymph Node Disease 43 0.035
354
HRL004 Hurler-Scheie Syndrome 43 0.035
355
PRS042 Prostate Disease 42 0.035
356
c VTL009 Vitiligo-Associated Multiple Autoimmune Disease Susceptibility 6 42 0.035
357
c MJR024 Major Affective Disorder 9 42 0.035
358
c MCR112 Microvascular Complications of Diabetes 2 42 0.035
359
HMN016 Hemangioendothelioma 41 0.035
360
MYX004 Myxedema 41 0.035
361
CNT060 Central Serous Chorioretinopathy 41 0.035
362
CHN053 Chondromyxoid Fibroma 40 0.035
363
EST007 Estrogen Resistance 40 0.035
364
PST036 Posterior Column Ataxia with Retinitis Pigmentosa 39 0.035
365
MCP033 Mucopolysaccharidoses 39 0.035
366
HPT070 Hepatosplenic T-Cell Lymphoma 39 0.035
367
c MJR022 Major Affective Disorder 8 39 0.035
368
P CRB059 Cerebellar Degeneration 38 0.035
369
c LBR018 Leber Congenital Amaurosis 8 38 0.035
370
48X005 48,xyyy 37 0.035
371
BCK003 Background Diabetic Retinopathy 37 0.035
372
c LBR011 Leber Congenital Amaurosis 16 37 0.035
373
BLT001 Bilateral Retinoblastoma 37 0.035
374
P MSN005 Mesenchymal Chondrosarcoma 37 0.035
375
CRT012 Cortical Blindness 37 0.035
376
c LBR016 Leber Congenital Amaurosis 6 37 0.035
377
AMR003 Amaurosis Fugax 36 0.035
378
c JBR041 Joubert Syndrome 3 36 0.035
379
c LBR005 Leber Congenital Amaurosis 10 36 0.035
380
ACT177 Acute Basophilic Leukemia 35 0.035
381
CRB159 Cerebral Visual Impairment 35 0.035
382
c MJR008 Major Affective Disorder 2 35 0.035
383
ASK001 Askin's Tumor 35 0.035
384
c CNG195 Congenital Disorder of Glycosylation, Type Id 35 0.035
385
CRB006 Cribriform Carcinoma 35 0.035
386
P CNR031 Cone-Rod Dystrophy, X-Linked, 1 34 0.035
387
c MNT185 Mental Retardation, Autosomal Dominant 7 34 0.035
388
c MJR003 Major Affective Disorder 6 34 0.035
389
c MJR006 Major Affective Disorder 5 34 0.035
390
RFM001 Roifman Syndrome 34 0.035
391
c DNT047 Dentinogenesis Imperfecta Type 2 34 0.035
392
c MJR023 Major Affective Disorder 7 34 0.035
393
c MNS014 Monosomy 22 33 0.035
394
OPT001 Optic Disk Drusen 33 0.035
395
c RTN056 Retinitis Pigmentosa 28 33 0.035
396
SVR002 Severe Nonproliferative Diabetic Retinopathy 33 0.035
397
c CNR014 Cone-Rod Dystrophy 16 33 0.035
398
c CRD216 Ceroid Lipofuscinosis, Neuronal, 9 32 0.035
399
MNC001 Monocular Esotropia 32 0.035
400
c MSC045 Muscular Dystrophy-Dystroglycanopathy , Type a, 3 32 0.035
401
ISC001 Ischemic Neuropathy 32 0.035
402
PLY150 Polykaryocytosis Inducer 31 0.035
403
SSC001 Susac Syndrome 31 0.035
404
CLR132 Colorblindness, Partial, Deutan Series 31 0.035
405
MCH006 Mechanical Strabismus 31 0.035
406
c RTN114 Retinitis Pigmentosa 58 30 0.035
407
c LBR009 Leber Congenital Amaurosis 14 30 0.035
408
CHN003 Chondroblastic Osteosarcoma 30 0.035
409
PST092 Posttransplant Acute Limbic Encephalitis 29 0.035
410
c MJR004 Major Affective Disorder 4 29 0.035
411
MYP067 Myopathy, Distal, Tateyama Type 29 0.035
412
XLN012 X-Linked Congenital Stationary Night Blindness 29 0.035
413
c JBR013 Joubert Syndrome 8 28 0.035
414
c NNS043 Nonsyndromic Retinitis Pigmentosa 28 0.035
415
AMT001 Ametropic Amblyopia 27 0.035
416
c SNR004 Senior-Loken Syndrome 4 26 0.035
417
CRY010 Cryptophthalmos 25 0.035
418
c PRS134 Prostate Cancer, Hereditary, 3 25 0.035
419
BTH002 Bothnia Retinal Dystrophy 25 0.035
420
EXT012 Extraskeletal Chondroma 25 0.035
421
MYT026 Myotonia Atrophica 25 0.035
422
c PRX066 Peroxisome Biogenesis Disorder 3b 25 0.035
423
CLR005 Clear Cell Chondrosarcoma 24 0.035
424
c LBR017 Leber Congenital Amaurosis 7 24 0.035
425
c NGH030 Night Blindness, Congenital Stationary, Type 1f 24 0.035
426
c LBR006 Leber Congenital Amaurosis 11 23 0.035
427
c RTN032 Retinal Cone Dystrophy 1 23 0.035
428
c RTN180 Retinitis Pigmentosa 74 23 0.035
430
c MCL061 Macular Dystrophy, Vitelliform, 4 21 0.035
431
RRV005 Rare Vascular Tumor 20 0.035
432
LTT006 Littoral Cell Angioma of the Spleen 20 0.035
433
PHC015 Phacoanaphylactic Uveitis 20 0.035
434
RTC011 Reticular Dystrophy of Retinal Pigment Epithelium 18 0.035
435
RTN037 Retinal Degeneration with Nanophthalmos, Cystic Macular Degeneration, and Angle Closure Glaucoma 18 0.035
436
INT334 Intellectual Developmental Disorder and Retinitis Pigmentosa 17 0.035
437
ACT235 Acute Macular Neuroretinopathy 16 0.035
438
SYN149 Syndromic Rod-Cone Dystrophy 16 0.035
439
PRP099 Peripheral Cone Dystrophy 14 0.035
441
OPT069 Optic Atrophy with Negative Electroretinograms 8 0.035
Content
Loading form....